CD8A and atherosclerosis: Therefore, monitoring these biomarkers associated with endothelial dysfunction and understanding the role of CD8+ T lymphocytes in atherosclerosis may pave the way for the early detection of pathological conditions and even inform novel therapeutic approaches [82].